← Leaderboards
John Y Dong
Medical University Of South Carolina
$5,010,666
Attributed
$5,010,666
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2006–09$2M$1.5M$1M$500K$0
'06
'07
'08
'09
Funding mix
By agency
NIH$5,010,666 · 2
By mechanism
U01$4,238,466 · 1
R01$772,200 · 1
Top collaborators
No co-investigators on record.
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- James S Norris$2,883,665
- Janardan P Pandey$4,092,394
- Joy N Jones Buie$188,764
- W Timothy Garvey$15,668,226
Others in their field
Top investigators on “Gene Delivery System”
- David Heimbrook · Leidos Biomedical Research, Inc.$54,204,250
- Tracey Devoir · Booz Allen Hamilton, Inc.$49,200,509
- Robert H Vonderheide · University Of Pennsylvania$45,163,553
- James Ter Maat · Social And Scientific Systems, Inc.$39,837,019
- Deborah T Hung · Massachusetts General Hospital$33,879,357
- Jeffrey S Chamberlain · University Of Michigan At Ann Arbor$32,336,372
Research focus
Gene Delivery SystemBiotechnologyHelper VirusTechnology /Technique DevelopmentAdenoviridaeCytotoxic T LymphocyteEpstein Barr VirusGene TherapyTransfection /Expression VectorTissue /Cell CultureAdverse EffectsAntigensAgreementBaseAntibody FormationAfricanAdenovirusesAntibodiesCategoriesBloodCell Mediated Immune ResponseCellsClinical DataAnimals
Grant awards (8)
Preclinical evaluation of a trivalent Marburg vaccine$1,083,681
U01 · FY2009 · AI · contact PI
Preclinical evaluation of a trivalent Marburg vaccine$1,087,854
U01 · FY2008 · AI · contact PI
Preclinical evaluation of a trivalent Marburg vaccine$1,092,086
U01 · FY2007 · AI · contact PI
Preclinical evaluation of a trivalent Marburg vaccine$974,845
U01 · FY2006 · AI · contact PI
Persistent Adeno-EBV Vectors for Gene Therapy$193,050
R01 · FY2004 · DK
Persistent Adeno-EBV Vectors for Gene Therapy$193,050
R01 · FY2003 · DK
Persistent Adeno-EBV Vectors for Gene Therapy$193,050
R01 · FY2002 · DK
Persistent Adeno-EBV Vectors for Gene Therapy$193,050
R01 · FY2001 · DK